During the past decade, Virgo-Carter Pediatrics conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Virgo-Carter Pediatrics" #1 collaborator was "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator, "Sanofi" with 1 trials as a collaborator, "Sucampo AG" with 1 trials as a collaborator and "Takeda" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Virgo-Carter Pediatrics" are "Constipation - Functional" (2 trials), "Acute Otitis Media" (1 trials), "Asthma" (1 trials) and "Functional Constipation" (1 trials). Many other conditions were trialed in "Virgo-Carter Pediatrics" in a lesser frequency.

Most popular intervention types in "Virgo-Carter Pediatrics" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Lubiprostone" (2 trials), "Placebo" (2 trials), "AR01" (1 trials), "DUPIXENT®" (1 trials) and "Glycerin ear drops" (1 trials). Other intervention names were less common.

The vast majority of trials in "Virgo-Carter Pediatrics" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Virgo-Carter Pediatrics". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Virgo-Carter Pediatrics, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Virgo-Carter Pediatrics, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".